CareRx Corporation
CHHHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $367 | $371 | $382 | $263 |
| % Growth | -1.1% | -2.9% | 45.3% | – |
| Cost of Goods Sold | $259 | $266 | $272 | $187 |
| Gross Profit | $108 | $105 | $110 | $75 |
| % Margin | 29.5% | 28.2% | 28.8% | 28.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $33 | $31 | $34 | $25 |
| SG&A Expenses | $33 | $31 | $34 | $25 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $71 | $69 | $68 | $45 |
| Operating Expenses | $104 | $100 | $102 | $70 |
| Operating Income | $5 | $5 | $8 | $5 |
| % Margin | 1.2% | 1.3% | 2.1% | 1.8% |
| Other Income/Exp. Net | -$9 | -$14 | -$14 | -$20 |
| Pre-Tax Income | -$4 | -$10 | -$36 | -$24 |
| Tax Expense | $0 | -$4 | -$2 | -$1 |
| Net Income | -$5 | -$5 | -$34 | -$23 |
| % Margin | -1.2% | -1.5% | -9% | -8.7% |
| EPS | -0.075 | -0.094 | -0.72 | -0.65 |
| % Growth | 20.5% | 86.9% | -10.8% | – |
| EPS Diluted | -0.075 | -0.094 | -0.72 | -0.65 |
| Weighted Avg Shares Out | 60 | 57 | 48 | 35 |
| Weighted Avg Shares Out Dil | 60 | 57 | 48 | 35 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $9 | $14 | $15 | $14 |
| Depreciation & Amortization | $19 | $20 | $20 | $15 |
| EBITDA | $24 | $25 | -$1 | $20 |
| % Margin | 6.5% | 6.6% | -0.2% | 7.7% |